November 19 – November 23, 2024
Bio-Techne Investors Website
Where Science Intersects Innovation™
As Bio-Techne, we have united multiple brands to provide a unique and comprehensive product portfolio. Together, our brands provide world class products and services for life-science research and clinical applications.
Upcoming Events
69.5%
Adjusted gross margin of 69.5%
$0.42
Adjusted EPS of $0.42
$289.5
Revenue of $289.5 million
Sign up for E-Mail Alerts
Sign up today
Price
Change
Volume
Day Range
52 Week Range
Company Overview
Bio‑Techne is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics. Whether you’re at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our award-winning tools and solutions empower scientists and clinicians to achieve reproducible and consistent results. Trusting Bio‑Techne means choosing confidence that every solution you use will help move you toward better answers.
Fast Facts
Net Sales (July 2023 to June 2024)
$1.2 Billion
Employees Worldwide
~3,100
Products
500,000+
Journal citations
350,000+
Incorporated in Minneapolis, Minnesota
1981
IR Contact Information
Company Information
Corporate Secretary
614 McKinley Place NE
Minneapolis, MN 55413
Investor Relations
David Clair
T: 612-656-4416
ir@bio-techne.com
Transfer Agent
American Stock Transfer
6201 15th Avenue
Brooklyn, NY 11219
T: 800-937-5449
help@astfinancial.com